A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to assess the biological activity of CP-4126 in patients
with advanced pancreatic cancer. In addition, the correlation between hENT1 (human
equilibrative nucleoside transporter 1) and overall survival will be studied.